The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer. Goring, S. M., Briggs, A., Penrod, J., Fan, S., Waser, undefined, Thompson, J. C., Wilson, J. B., Wang, S., Korytowsky, B., Chirita, O., Hertel, N., & Yuan, Y. Value in Health, 20(9):A421, October, 2017.
The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer [link]Paper  doi  bibtex   
@article{goring_validity_2017-1,
	title = {The {Validity} of {Objective} {Response} {Rate} {As} {A} {Surrogate} {For} {Progression}-{Free} {And} {Overall} {Survival} {In} {The} {Evaluation} of {First}-{Line} {Chemotherapy} {For} {Advanced} {Non}-{Small} {Cell} {Lung} {Cancer}},
	volume = {20},
	issn = {10983015},
	url = {https://linkinghub.elsevier.com/retrieve/pii/S1098301517304692},
	doi = {10.1016/j.jval.2017.08.135},
	language = {en},
	number = {9},
	urldate = {2019-10-08},
	journal = {Value in Health},
	author = {Goring, S. M. and Briggs, A. and Penrod, J. and Fan, S. and Waser, , N and Thompson, J. C. and Wilson, J. B. and Wang, S. and Korytowsky, B. and Chirita, O. and Hertel, N. and Yuan, Y.},
	month = oct,
	year = {2017},
	keywords = {oncology},
	pages = {A421},
}

Downloads: 0